ReviewCurrent oncology (Toronto, Ont.)2025

Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC).

Khashayar Yazdanpanah Ardakani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.